Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1368 ARTÍCULOS , VIENDO DEL 496 AL 510
Anthocyanins Potentially Contribute to Defense against Alzheimer's Disease
Afzal M, Redha A, AlHasan R.
Molecules. 2019 Nov 22;24(23):4255. doi: 10.3390/molecules24234255.
Mega-Analysis of Gene Expression in Mouse Models of Alzheimer's Disease
Zhuang B, Mancarci BO, Toker L, Pavlidis P.
eNeuro. 2019 Dec 4;6(6):ENEURO.0226-19.2019. doi: 10.1523/ENEURO.0226-19.2019. Print 2019 Nov/Dec.
Choubey D.
J Neuroinflammation. 2019 Nov 26;16(1):236. doi: 10.1186/s12974-019-1639-5.
Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood
Lardenoije R, Roubroeks JAY, Pishva E, Leber M, Wagner H, Iatrou A, Smith AR, Smith RG, Eijssen LMT, Kleineidam L, Kawalia A, Hoffmann P, Luck T, Riedel-Heller S, Jessen F, Maier W, Wagner M, Hurlemann R, Kenis G, Ali M, Del Sol A, Mastroeni D, Delvaux E, Coleman PD, Mill J, Rutten BPF, Lunnon K, Ramirez A, van den Hove DLA.
Clin Epigenetics. 2019 Nov 27;11(1):164. doi: 10.1186/s13148-019-0755-5.
The use of Huperzia species for the treatment of Alzheimer's disease
Kim Thu D, Vui DT, Ngoc Huyen NT, Duyen DK, Thanh Tung B.
J Basic Clin Physiol Pharmacol. 2019 Nov 28;31(3):/j/jbcpp.2020.31.issue-3/jbcpp-2019-0159/jbcpp-2019-0159.xml. doi: 10.1515/jbcpp-2019-0159.
Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
Ahn KC, Learman CR, Baker GB, Weaver CL, Chung PS, Kim HG, Song MS.
J Korean Med Sci. 2019 Dec 2;34(46):e297. doi: 10.3346/jkms.2019.34.e297.
Organotypic brain slice cultures to model neurodegenerative proteinopathies
Croft CL, Futch HS, Moore BD, Golde TE.
Mol Neurodegener. 2019 Dec 2;14(1):45. doi: 10.1186/s13024-019-0346-0.
[Alzheimer's disease therapy: challenges and perspectives.]
Orlov MA.
Adv Gerontol. 2019;32(4):639-651.
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease
Jia L, Piña-Crespo J, Li Y.
Mol Brain. 2019 Dec 4;12(1):104. doi: 10.1186/s13041-019-0525-5.
[Alzheimer's disease and singing: an application in mediated therapy]
Hamm S, Sudres JL, Menouer L, Brandibas G.
Soins Gerontol. 2019 Nov-Dec;24(140):15-19. doi: 10.1016/j.sger.2019.09.004.
[Mobile applications in alzheimer's disease. A systematic review of the literature]
Sánchez-Gutiérrez C, Ortega-Bastidas P, Cano-de-la-Cuerda R.
Rehabilitacion (Madr). 2019 Oct-Dec;53(4):247-275. doi: 10.1016/j.rh.2019.07.002. Epub 2019 Nov 18.
Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer's disease
Wirths O, Zampar S.
Expert Opin Ther Targets. 2019 Dec;23(12):991-1004. doi: 10.1080/14728222.2019.1702972. Epub 2019 Dec 12.
β-amyloid and Oxidative Stress: Perspectives in Drug Development
Caruso G, Spampinato SF, Cardaci V, Caraci F, Sortino MA, Merlo S.
Curr Pharm Des. 2019;25(45):4771-4781. doi: 10.2174/1381612825666191209115431.
Oxidative DNA Damage Signalling in Neural Stem Cells in Alzheimer's Disease
Kieroń M, Żekanowski C, Falk A, Wężyk M.
Oxid Med Cell Longev. 2019 Nov 13;2019:2149812. doi: 10.1155/2019/2149812. eCollection 2019.
Teixeira JP, de Castro AA, Soares FV, da Cunha EFF, Ramalho TC.
Molecules. 2019 Dec 3;24(23):4410. doi: 10.3390/molecules24234410.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.